GW Pharmaceuticals (GWPH) Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2019

– Epidiolex U.S. Q2 net sales of $68.4 million – – Positive…

Marijuana Stocks That Have Yet to Reach Their Full Potential 

Marijuana stocks have continuously illustrated their potential for success in the coming…

These Marijuana Stocks Are Taking on Big Projects for the Future

The marijuana industry has been known to be fueled by innovation and…

Marijuana Stocks Continue to Excite Investors With Record Revenues

The marijuana stock market has been moving forward with a large amount…

Smaller Companies Could be the Key to Success for Marijuana Stock Investors

The marijuana industry is quite heavily dominated by the largest five growers…

GW Pharmaceuticals plc (GWPH) and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex®

GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data on Epidiolex®…

The End of March Rides High for Marijuana Stocks Across the Industry

The month of March has already shown a great deal of promise…

Underground Marijuana Stocks Show Gains as Market Continues to Grow

While many who invest in the cannabis industry are focused on the…